UC Team Studies Link Between Parkinson's and Depression
CINCINNATI--A patient who receives a diagnosis of Parkinsons disease might become depressed, and understandably so. But does the depression then exacerbate the progression of Parkinsons? Thats one of the questions a team of Parkinsons disease is a degenerative neurological disorder involving the death of dopamine-producing cells, or neurons, deep within the brain. Depression is highly prevalent in Parkinsons disease, previous research has found. Principal investigator Kim Seroogy, PhD, and co-investigator James Herman, PhD, are studying a stress-induced model of depression and Parkinsons in rodents. Seroogy is a professor of neurology and director of the Selma Schottenstein Harris Lab for Research in Parkinsons at the James J. and Parkinsons-induced rodents are stressed in a variety of ways, such as being placed briefly in a cold room or a crowded setting. In studying the results, the UC team hopes to gain insight into a problem Seroogy likens to the classic chicken-and-egg question: Which comes first, Parkinsons or depression? There are two schools of thought on co-morbidity of depression and Parkinsons, says Seroogy. One is that the onset of depression precedes and possibly leads to Parkinsons. The other is that Parkinsons disease predisposes for depression. Clinically, theres evidence for both of those lines of thinking. The NIH grant will enable the UC team to examine the question and, as Seroogy puts it, have it surrounded. Were going to have some groups that undergo depression first, then the Parkinsons, and then well do the reverse, he says. Then there will be some that are combineddepression, then parkinsonism, then further depression. In pilot models so far, Seroogy and Herman have found that in those animals that have stress combined with Parkinsons, their normal loss of dopamine cells in the brain is accelerated. In addition, the movements of their impaired limbs also worsened in the behaviors that were tested. So stress-induced depression exacerbates problems with movement, and also causes the relevant brain cells to die faster, Seroogy says. Learning more about the relationship between depression and Parkinsons will provide insight into possible treatments of Parkinsons, Seroogy says. You might ask, Why dont we just prescribe antidepressants? he adds. Well, we do. But there are no really definitive epidemiological studies or long-term assessments of the effects of antidepressants on the progression of Parkinsons. Seroogy and Herman will explore that, plus the possibility that antidepressants can protect the brain from Parkinsons disease. Not only could they reduce depression, but they might actually protect dopamine cells in the brain and thus slow the progression of Parkinsons, says Seroogy. Seroogy and Herman began their research into depression and Parkinsons with a $14,000 grant from the Sunflower Revolution Encore, a private fund-raiser hosted by Melody Sawyer Richardson in 2005. Two years later, they received a $50,000 grant from the Davis Phinney Foundation to continue their research, which was also supported in the interim by about $20,000 from the Parkinsons Disease Support Network of Were gratified that an investment in our research by the local community and the Davis Phinney Foundation has now led to a five-year NIH grant that will allow us to investigate how stress causes enhanced parkinsonian symptoms, and how to prevent stress from causing further damage to the parkinsonian brain, says Seroogy. The Sunflower Revolution is an annual gala, symposium and bike ride that raises funds for the Neuroscience Institute at UC and Phinney, 49, is one of only three Americans to win multiple stages of the Tour de France. His 300 national and international victories make him This years Sunflower Revolution V events are scheduled for Sept. 5 (gala at the Hyatt Regency in downtown
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.